Science
Waisman Biomanufacturing partners with GigaGen to manufacture new COVID-19 drug – Mirage News
Waisman Biomanufacturing at the University of Wisconsin-Madison will begin manufacturing a new drug to treat and prevent COVID-19, developed by…
Waisman Biomanufacturing at the University of Wisconsin-Madison will begin manufacturing a new drug to treat and prevent COVID-19, developed by California-based biotech company GigaGen.
The drug, called GIGA-2050, uses a new approach similar to treating COVID-19 patients with convalescent plasma, or blood products from people recovering (convalescing) from an infection. Waisman Biomanufacturing was created to facilitate just this sort of development and testing of new types of drugs.
“Our miss…
-
General12 hours agoChina and Philippines trade blame over latest South China Sea clash
-
Noosa News16 hours agoWest End icon closes doors
-
General19 hours agoCalls for government to ‘get on with’ CSIRO Ginninderra Experiment Station land sale after three-year delay
-
Noosa News24 hours agoCat-Sitting Leads to Chaos for Austin Butler in the Trailer for Darren Aronofsky’s New Crime-Thriller ‘Caught Stealing’